Name | Value |
---|---|
Revenues | 27.0M |
Cost of Revenue | 15.9M |
Gross Profit | 11.2M |
Operating Expense | 32.3M |
Operating I/L | -21.1M |
Other Income/Expense | 0.3M |
Interest Income | 0.0M |
Pretax | -20.8M |
Income Tax Expense | 0.1M |
Net Income/Loss | -20.8M |
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. Its product line includes analytical systems, assays and reagents, preparatory instruments, integrated fluidic circuits, single cell microfluidics, and software solutions. The company serves academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, biopharmaceutical, biotechnology, and plant and animal research companies, and contract research organizations. Standard BioTools Inc. generates revenue through the sale of its diverse range of products and services to a wide array of customers in the research and clinical laboratory sectors.